Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioblastoma × Basiliximab × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Temozolomide 99 Radiotherapy 56 Radiation 26 Bevacizumab 17 Magnetic Resonance Spectroscopy 13 Nivolumab 11 Irinotecan 10 Cyclophosphamide 9 Surgical Procedures, Operative 8 Specimen Handling 8 pembrolizumab 7 motexafin gadolinium 7 Radiotherapy, Intensity-Modulated 7 Radiosurgery 7 O(6)-benzylguanine 7 Flucytosine 7 Chemotherapy, Adjuvant 7 sargramostim 6 poly ICLC 6 Leukapheresis 6 Erlotinib Hydrochloride 6 Carmustine 6 fludarabine 5 Radiotherapy, Conformal 5 Lomustine 5 Imiquimod 5 Imatinib Mesylate 5 Hydroxyurea 5 Drug Therapy 5 vocimagene amiretrorepvec 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00626483 2021-03-09

REGULATe

Duke University

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡